Potassium disturbance associated with an inpatient childhood asthma pathway.

ABSTRACT:

Background

Paediatric asthma exacerbations in Alberta are treated via standardized order sets known as the Alberta Acute Childhood Asthma Pathway (ACAP). This pathway is utilized in paediatric tertiary hospitals and in remote and rural locations. Incidence, magnitude, and risk factors for hypokalemia in inpatients receiving salbutamol for asthma exacerbations via this pathway are presently unknown.

Objective

Establish incidence, magnitude, and risk factors for hypokalemia associated with salbutamol therapy as directed by a paediatric asthma pathway.

Methods

Retrospective cohort study using visit-level electronic medical data. Inpatients aged <18 years old receiving salbutamol via the ACAP with at least one potassium level were included. Hypokalemia was defined as mild

SUBMITTER: Hung J 

PROVIDER: S-EPMC7739532 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature